1. 1) Péterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet., 27, 121–124 (2001).
2. 2) Reue K, Xu P, Wang XP, Slavin BG. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J. Lipid Res., 41, 1067–1076 (2000).
3. 3) Langner CA, Birkenmeier EH, Benzeev O, Schotz MC, Sweet HO, Davisson MT, Gordon JI. The fatty liver dystrophy (Fld) mutation—a new mutant mouse with a developmental abnormality in triglyceride-metabolism and associated tissue-specific defects in lipoprotein–lipase and hepatic lipase activities. J. Biol. Chem., 264, 7994–8003 (1989).
4. 4) Phan J, Reue K. Lipin, a lipodystrophy and obesity gene. Cell Metab., 1, 73–83 (2005).
5. 5) Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr, Kelly DP. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab., 4, 199–210 (2006).